Xofigo 1,100 KBQ/ML vials
Ended Awarded
- Contract number
- SPE2DB25FDK86
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,314
Award facts
- Contract value 100% obligated
- $18,313.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $18,313.56 firm fixed-price delivery order from the Defense Logistics Agency on August 1, 2025, for XOFIGO 1,100 KBQ/ML vials. The contract, which carries no set-aside designation, is scheduled for completion by August 22, 2025, and will be performed at the contractor's Park Ridge facility. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026, which enables the issuance of firm fixed-price orders for pharmaceutical products supporting Department of Defense healthcare needs.
XOFIGO is a radiopharmaceutical treatment used in oncology for metastatic castration-resistant prostate cancer, reflecting the Defense Logistics Agency's role in procuring specialized medical supplies for military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently winning contracts for branded and generic prescription drugs, biologics, and medical consumables across diverse therapeutic categories. The company's positioning as a woman-owned small business has enabled it to compete effectively in federal procurement markets while maintaining a robust portfolio of pharmaceutical product deliveries to military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FDK86?
SPE2DB25FDK86 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FDK86 worth?
The government has obligated $18,314 on SPE2DB25FDK86.
Is contract SPE2DB25FDK86 an order under another contract?
Yes. SPE2DB25FDK86 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDK86 competed?
The extent of competition for SPE2DB25FDK86 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award